| | Author | Sex/age | Lymphoma | Gastric adenocarcinoma | Nodes | Follow-up | Adjuvant treatment |
| | Jernstrom and Murray [9], 1966 | F/72 | Lymphosarcoma | WD, I | L/GA (+) | 10 m | Radiotherapy |
| |
Manier and Reyes [3], 1974 | M/65 | Histiocytic | EGC, PD | L (+) | 24 m | Chemotherapy | | M/72 | Histiocytic | EGC, PD | L/GA (+) | 1,5 m (DOS) | None |
| |
Planker et al. [47], 1984 | M/65 | Immunocytoma | EGC, MD, I | L (+) | N/A | Radiotherapy |
| | Kasahara et al. [4], 1988 | F/72 | Small cleaved B cells | WD | (−) | 48 m | N/A |
| | Noda et al. [38], 1989 | M/69 | Large-cell type | EGC, WD | (−) | 9 m | Chemotherapy |
| |
Wotherspoon and Isaacson [24], 1995 | F/55 | MALT | WD, D | GA (+) | N/A | N/A | | F/55 | MALT | AGC, WD, I | GA (+) | N/A | N/A | | M/N/A | MALT | AGC, WD, I | (−) | N/A | N/A | | F/69 | MALT | AGC, WD, I | L/GA (+) | N/A | N/A |
| | Nishino et al. [13], 1996 | M/71 | Diffuse large cell | WD | (−) | 120 m | Chemotherapy |
| |
Nakamura et al. [14], 1997 | M/42 | Immunoblastic | EGC, PD, D | (−) | 91 m | None | | M/47 | Superficial MALT | EGC, PD, D | (−) | 24 m | Chemotherapy | | M/53 | Superficial MALT | EGC, WD, I | (−) | 67 m (DOD) | None | | F/67 | Superficial MALT | EGC, WD, I | (−) | 31 m (DOD) | None | | M/78 | T cell, pleomorphic | AGC, PD, D | GA (+) | 1 m (DOS) | None |
| |
Goteri et al. [6], 1997 | M/51 | MALT | EGC, WD, I | (−) | 122 m | N/A | | F/55 | MALT | EGC, PD, D | (−) | 33 m | N/A | | M/80 | MALT | EGC, WD, I | L (+) | 12 m | N/A | | M/57 | MALT | EGC, WD, I | L (+) | 10 m (DOD) | N/A |
| | Suenaga et al. [23], 2003 | M/73 | MALT | AGC, WD, I | GA (+) | 23 m (DOD) | N/A |
| | Isaka et al. [48], 2007 | F/63 | MALT | N/A | N/A | 2 m (DOD) | N/A |
| |
Bhattacharya et al. [29], 2012 | M/55 | NHL | WD | N/A | N/A | N/A | | M/67 | NHL | N/A | N/A | N/A | N/A |
| | Yanagawa et al. [15], 2012 | M/72 | HL | PD | L (+) | N/A | N/A |
| | George and Junaid [49], 2014 | M/53 | MALT | SRC | N/A | 2 m | N/A |
|
|
